CD4⁺CD25⁺ regulatory T cells: a therapeutic target for liver diseases

Author： Zheng Ming-Hua Gu Dian-Na Braddock Martin Leishman Andrew J Jin Chang Wen Jin-Sheng Gong Yue-Wen Chen Yong-Ping

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.3, 2008-03, pp. : 313-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Generation and Antigen-Specificity of CD4+CD25+ Regulatory T Cells

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-09 ,pp. : 149-156

Bentham Science Publishers

Access to resources Recommend Favorite

CD133⁺⁺ cells as a therapeutic target for kidney diseases

By Bussolati Benedetta Collino Federica Camussi Giovanni

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 157-165

Informa Healthcare

Access to resources Recommend Favorite

Leflunomide induces immunosuppression in collagen-induced arthritis rats by upregulating CD4⁺CD25⁺ regulatory T cells

By Wang Ting-Yu Li Jun Li Chang-Yu Jin Yong Lü Xiong-Wen Wang Xiao-Hua Zhou Qian

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 1, 2010-01 ,pp. : 45-53

NRC Research Press

Access to resources Recommend Favorite

CD4+CD25+ T Regulatory Cells and TGF-&bgr; in Mucosal Immune System: The Good and the Bad

Current Medicinal Chemistry, Vol. 14, Iss. 21, 2007-09 ,pp. : 2245-2249

Bentham Science Publishers

Access to resources Recommend Favorite

The Janus Face of CD4+CD25+ Regulatory T Cells in Cancer and Autoimmunity

Current Medicinal Chemistry, Vol. 14, Iss. 6, 2007-03 ,pp. : 649-666

Bentham Science Publishers

Access to resources Recommend Favorite